Evidence map›Paper›PMID 40796201›Full record

ArticleInternational health2026

Oral cholera vaccine uptake, acceptance and confidence among residents of a high-risk township in Zambia: key insights for future vaccination programs.

Ernest Miti, Moses Mukosha, John Mwaba, Malala Mulavu, Johanna C Meyer, Steward Mudenda, Brian Godman, Chiluba Mwila, Audrey Hamachila, Aubrey C Kalungia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ernest MitiDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.
Moses MukoshaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID 0000-0002-6079-0564
John MwabaInstitute of Basic and Biomedical Sciences, Levy Mwanawasa Medical University, P.O. Box 33991, Lusaka, Zambia.
Malala MulavuNational Health Research Authority, P.O. Box 30075, Lusaka, Zambia.ORCID 0000-0001-5326-8877
Johanna C MeyerDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, P.O. Box 60, Ga-Rankuwa, Pretoria, South Africa.ORCID 0000-0003-0462-5713
Steward MudendaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID 0000-0003-1692-8981
Brian GodmanDepartment of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, P.O. Box 60, Ga-Rankuwa, Pretoria, South Africa.ORCID 0000-0001-6539-6972
Chiluba MwilaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID 0000-0003-0160-1222
Audrey HamachilaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID 0009-0004-6650-5738
Aubrey C KalungiaDepartment of Pharmacy, School of Health Sciences, University of Zambia, P.O. Box 50110, Lusaka, Zambia.ORCID 0000-0003-2554-1236

Funding

Ministry of Health
6 · The paper itself

Abstract

backgroundOral cholera vaccines (OCVs) prevent cholera and save lives. Given the recent 2024 country-wide cholera epidemic in Zambia, we determined self-reported OCV uptake, acceptance and confidence among adults living in a high-risk, cholera-prone township in Zambia.

methodsA descriptive cross-sectional study was conducted from April to August 2024, involving 385 randomly selected adult participants residing in the Kanyama township of Lusaka, Zambia. Data were collected using an interviewer-administered questionnaire and statistically analysed.

resultsSelf-reported uptake of at least one dose of the OCV was 18%, with the majority (315 [82%]) reporting being unvaccinated against cholera. Among those who were unvaccinated, vaccine acceptance was <10% (95% confidence interval [CI] 6.8 to 13.7), with higher rates reported among women than men (p=0.002). Despite this, the majority (210 [84.3%]) expressed confidence in the vaccination program. Those knowledgeable about the OCV were twice as likely to get vaccinated (adjusted odds ratio 2.60 [95% CI 1.19 to 5.68]). Knowledge, attitudes and perceptions were associated with OCV uptake.

conclusionsSelf-reported OCV uptake and acceptance were low in a high-risk cholera-prone township in Zambia. Community education on the benefits of the vaccine is urgently needed to enhance confidence and attitudes towards the OCV and improve vaccination rates in the future.

Indexed as

CholeraCholera VaccinesHealth Knowledge, Attitudes, PracticePatient Acceptance of Health CareVaccinationAdministration, OralAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultZambiaCholera Vaccinesacceptanceconfidencehesitancyoral cholera vaccineuptakevaccination

Identifiers

PMID40796201
PMCPMC13016622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.